key: cord-0819724-ubhugslt
authors: Salsano, Antonio; Liao, Jingda; Miette, Ambra; Capoccia, Massimo; Mariscalco, Giovanni; Santini, Francesco; Corno, Antonio F.
title: Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis
date: 2021-03-09
journal: Open Med (Wars)
DOI: 10.1515/med-2021-0242
sha: 2411d0a06ceceb1a9e00b764122f663a9ed08fde
doc_id: 819724
cord_uid: ubhugslt

BACKGROUND: Kawasaki disease (KD) is a systemic inflammatory condition occurring predominantly in children. Coronary artery bypass grafting (CABG) is performed in the presence of inflammation and aneurysms of the coronary arteries. The objectives of our study were to assess which CABG strategy provides better graft patency and early and long-term outcomes. METHODS: A systematic review using Medline, Cochrane, and Scopus databases was performed in February 2020, incorporating a network meta-analysis, performed by random-effect model within a Bayesian framework, and pooled prevalence of adverse outcomes. Hazard ratios (HR) and corresponding 95% credible intervals (CI) were calculated by Markov chain Monte Carlo methods. RESULTS: Among 581 published reports, 32 studies were selected, including 1,191 patients undergoing CABG for KD. Graft patency of internal thoracic arteries (ITAs), saphenous veins (SV), and other arteries (gastroepiploic artery and radial artery) was compared. ITAs demonstrated the best patency rates at long-term follow-up (HR 0.33, 95% CI: 0.17–0.66). Pooled prevalence of early mortality after CABG was 0.28% (95% CI: 0.00–0.73%, I (2) = 0%, tau(2) = 0), with 63/1,108 and 56/1,108 patients, undergoing interventional procedures and surgical re-interventions during follow-up, respectively. Pooled prevalence was 3.97% (95% CI: 1.91–6.02%, I (2) = 60%, tau(2) = 0.0008) for interventional procedures and 3.47% (95% CI: 2.26–4.68%, I (2) = 5%, tau(2) <0.0001) for surgical re-interventions. Patients treated with arterial, venous, and mixed (arterial plus second venous graft) CABG were compared to assess long-term mortality. Mixed CABG (HR 0.03, 95% CI: 0.00–0.30) and arterial CABG (HR 0.13, 95% CI: 0.00–1.78) showed reduced long-term mortality compared with venous CABG. CONCLUSIONS: CABG in KD is a safe procedure. The use of arterial conduits provides better patency rates and lower mortality at long-term follow-up.

Kawasaki disease (KD) is a systemic inflammatory condition occurring predominantly in children (80% of patients are younger than 5 years of age), first reported in 1974 as an acute febrile illness with mucocutaneous lesions and lymphadenopathy [1, 2] . The incidence of KD varies across the world from 19 to 265 cases per 1,00,000 in children less than 5 years of age [2] . It can be complicated by a systemic vasculitis with particular involvement of the coronary arteries; if left untreated, 20% of children could develop coronary artery aneurysm [2] . In the acute phase of the disease, inflammatory formation of coronary aneurysms can occur, eventually associated with rupture of the latter, while thrombosis or narrowing of the affected coronary arteries can complicate the late phases [2] [3] [4] [5] [6] . In high income countries, KD remains the leading cause of acquired heart disease in children, with complication such as acute myocardial infarction [2, [7] [8] [9] . Despite extraordinary results due to early recognition of the disease and treatment with intravenous administration of immunoglobulins [2, 10] , long-term studies showed that complications secondary to inflammation and aneurysmatic dilatation of the coronary arteries can still occur, with subsequent impairment of the left ventricular function [2, 8, 9, [11] [12] [13] [14] . Selective coronary angiography is indispensable in those situations to provide essential information for the decision making, before percutaneous or surgical myocardial revascularization [2, [14] [15] [16] [17] . Coronary artery bypass grafting (CABG) is performed in the presence of inflammation and aneurysms of the coronary arteries, using both arterial and/or venous grafts [17, 18] . In the literature, only retrospective studies about CABG after KD are found and no meta-analysis has been published until now; grafts' patency and long-term outcomes such as survival rates appear uncertain. Since the risk of progression of the systemic arteritis with formation of aneurysms in other arterial districts [19] , such as internal thoracic artery (ITA) [20] , the choice of the best type of surgical revascularization is still a matter of discussions [18] .

The objectives of our study were to assess which surgical strategy of CABG provides better graft patency and early and long-term outcomes, through a literature systematic review and a Bayesian network meta-analysis.

No ethical approval or review protocol was applicable for this study, since it was a review of existing literature. This work was in line with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines (see Supplementary Materials -Appendix 1).

Primary endpoint is graft patency for ITAs, saphenous veins (SV), and other conduits (gastroepiploic [GEA] and radial [RA] arteries). Patency assessment at follow-up was performed using either invasive angiography or noninvasive computed tomographic angiography, and significative coronary stenosis (>70%) or occlusions were considered non-patent grafts [8] .

Secondary endpoints were early mortality (in-hospital or 30-days mortality), need for interventional procedures and surgical re-interventions, and long-term mortality for arterial, venous, or mixed (arterial plus second venous graft) types of revascularization.

A systematic review using Medline, Cochrane, and Scopus databases has been performed in March 2020, incorporating a Bayesian network meta-analysis. A search strategy with a time interval from 1980 to 2020 was performed using the following search string for Medline ( 

Inclusion criteria for the study were: (1) subjects involved in the study were patients with KD who underwent surgical revascularization; (2) comparison between different surgical strategies of myocardial revascularization; (3) at least one of the endpoints has to be included, such as graft patency, early and long-term mortality, and need of interventional procedures and/or surgical re-interventions; (4) sufficient quality data should have been provided in the original studies. Exclusion criteria for the study: (1) case reports, conference proceedings or reviews;

(2) duplicates studies; (3) publications with full text in languages other than English. PICOS study design was used for inclusion/exclusion criteria (Table S1).

Three investigators (A. S., J. L., A. M.) independently identified and extracted all relevant data of eligible studies from original articles: first author's name, year of publication, numbers of patients, mean age at surgery, gender, surgical strategy of myocardial revascularization, number of grafts, and endpoints such as graft patency, early and long-term mortality, and need of interventional procedures and/or surgical re-interventions. Data were retrieved only from the articles, and no attempt was made to get missing data from the authors. Any disagreement was solved by consensus.

Study quality was assessed using the Newcastle-Ottawa Scale, a scale to evaluate the quality of non-randomized studies [21] , and the US Preventive Services Task Force [22] . The Cochrane Risk of Bias tool was also used to evaluate the methodological quality of all included studies [23] . Quality assessment of each study is presented in Tables S2-S5.

Baseline and early mortality data were pooled using meta-analysis of means or proportions, with individual study effect size accounted for using inverse variance methods. Results were displayed as values and percentages with 95% confidence intervals (CI) or 95% credible intervals (CrI). Graft patency and long-term mortality for arterial, venous, or mixed CABG were analyzed across all arm-level studies, with direct and indirect comparisons using a mixed-treatment comparison based on a Bayesian hierarchical model. HRs and corresponding 95% credible intervals were calculated by Markov chain Monte Carlo methods using the "BUGSnet" package of R software (version 3.6.3; R Foundation, Vienna, Austria) [24] . Brooks-Gelman-Rubin plots method, trace plot, and density plot were used to assess the model convergence [25] . Besides, rank probabilities were calculated to obtain the hierarchical amount effects of multiple treatments. Given the graft type, CABG modalities, and time period over which included studies were conducted, a randomeffect model was used. For the purposes of the mixedtreatment comparison, consistency in direct and indirect effects was assumed [26] . Heterogeneity between comparisons within the network was analyzed by examining I values for the random-effect model. Inconsistency was graphically examined using the BUGSnet nma.compare function to plot the individual data points' posterior mean deviance contributions for the consistency model versus the inconsistency model [27] . For early mortality, need of interventional procedures, and surgical re-interventions, a frequentist approach (meta-analysis of proportions) has been applied. Pooled prevalence of adverse outcome has been calculated using the package "meta" of R software [28] .

The systematic literature review from 1981 to 2019 provided the following results: 581 reports and, after duplicates removal, 261 were screened. After screening of titles and abstract, 92 papers were excluded. The full texts of the remaining 169 articles were evaluated, and 137 studies were excluded with reasons. A total of 32 articles (observational studies and case series, no randomized controlled trial), including 1,191 patients, were selected .

Patients were mostly male with a mean age of 12.17 years and received CABG using 1.79 grafts per patient on average ( Table 1) .

A PRISMA flow diagram of the study selection process can be found in Figure 1 . The quality assessment of the included studies is reported in Tables S2-S5. Detailed pooled patients' data are presented in Table 1 . For all studies, patients' characteristics, main surgical strategies, and early outcome results are summarized in Table 2. 3.2 Results from network meta-analysis 3.2.1 Primary outcome: graft patency Overall, 1,191 patients were included in the present metaanalysis, with an average of 1.79 (95% CI: 1.55-2.00) grafts per patient. ITA, RA or GEA, and SV conduits Summary results for all grafts patency at follow-up are shown in Figure 2a , with SV used as reference. These pooled results show that ITAs and other arteries (GEA and RA) are superior to SV. Rank probability analysis for graft patency at follow-up demonstrates that ITA had higher probabilities of being the first most effective treatment (Figure 2b) .

The efficacy of different treatments in terms of graft patency at follow-up using HR and corresponding 95% CrI is displayed in Figure 3 . Pairwise comparisons for graft patency at follow-up are shown in Figures S3a-c . I 2 demonstrated that heterogeneity was low for SV versus ITAs comparison and was moderate for SV and ITAs versus other arteries (GEA and RA). After comparison of consistency and inconsistency models through individual data points' posterior mean deviance contributions, we conclude that there is a lack of evidence to suggest inconsistency within the network ( Figure S4 ). 

In all 32 studies included in the meta-analysis, only 6 early deaths were reported among 1,191 patients. Pooled prevalence of early mortality after CABG was 0.28% (95% CI: 0.00-0.73%, I 2 = 0%, tau 2 = 0, Figure S5 ). Twenty six studies reported interventional procedures and surgical re-interventions rates: 63/1,108 and 56/1,108 patients underwent interventional procedures and surgical re-interventions at follow-up (mean 110.35 months, 95% CI: 28.50-264.00 months), respectively.

Pooled prevalence of interventional procedures was 3.97% (95% CI: 1.91-6.02%, I 2 = 60%, tau 2 = 0.0008, Figure S6 ). Across the studies that reported interventional procedures, high heterogeneity demonstrated elevated variability across the included studies.

Among the interventional procedures, percutaneous transluminal balloon angioplasty was performed only for graft stenosis, while percutaneous transluminal rotational ablation was done for coronary artery lesions. 7 DES stents were implanted for conduit stenoses (5 SVG graft, 1 ITA graft, and 1 RA graft). Pooled prevalence of surgical re-interventions was 3.47% (95% CI: 2.26-4.68%, I 2 = 5%, tau 2 <0.0001, Figure S7 ).

Patients treated with arterial, venous, and mixed (arterial plus second venous graft) CABG were compared to assess long-term mortality. Eight arm-level papers out of 32 studies were included to perform the network metaanalysis [31, 34, 39, [41] [42] [43] 49, 53] . Mean follow-up across studies for long-term mortality was 142.56 months (follow-up: min 48-max 264 months). Survival at follow-up after arterial, venous, and mixed CABG is 99.07 ± 2.27%, 83.33 ± 28.87%, and 99.87 ± 0.33%, respectively. The network model, trace plot, and density plot for long-term mortality are shown in Figures S8 and  S9 . Summary results are shown in Figure 4a , while rank probability analysis is shown in Figure 4b .

The efficacy of different treatments using HR and corresponding 95% CrI is displayed in Figure S10 . Pairwise comparisons at follow-up are shown in Figure S11a -c. There is a lack of evidence to suggest inconsistency within the network model ( Figure S12 ). Briefly, mixed CABG (HR 0.03, 95% CrI: 0.00-0.30) and arterial CABG (HR 0.13, 95% CrI: 0.00-1.78) showed reduced long-term mortality compared with venous CABG.

More in deep, focusing on the comparison between long-term mortality for arterial CABG vs. mixed CABG, we are facing with 58 single CABG out of a total of 133 cases (43.6%) in which at least one arterial conduit has been employed ( Figure S11c) [34, 39, 41, 42, 49] . It appears that the use of arterial conduit, even better if applied in a multiple CABG setting, provides benefits on long-term mortality. Although the low number of deaths at follow-up is a positive finding, caution is required in interpreting these results and it needs to be confirmed in future studies.

This network meta-analysis aimed to assess which CABG strategy provides better graft patency and long-term outcomes. Results from 32 studies with a total of 1,191 cases demonstrated that CABG for KD is a safe procedure with satisfying long-term outcomes.

Our systematic review and meta-analysis showed a low early mortality after CABG in KD, ranging between 0 and 1%. The excellent efficacy of surgical revascularization was also demonstrated by 10-year survival rates above 90%, with a 3.5-4% rate of interventional procedures or surgical re-interventions during the follow-up.

The choice of conduits in coronary artery surgery remains a debated and controversial issue, and the following points should be considered before CABG: the expected long-term patency of the graft, considering that the factors that may influence long-term patency are the presence of competitive flow from the native vessel or collaterals, further development of atherosclerosis, and abnormal coronary artery structure and function at the site of the anastomosis. The choice between arterial revascularization with ITA, free gastroepiploic artery, or free radial artery versus venous CABG with saphenous vein has to be well-discussed prior to surgery. The growth potential of the graft relative to the somatic growth of the patient, particularly in the pediatric age, has to be taken into account: ITA in situ appears to grow with the patient, but there are doubts on the growth of free grafts conduits. However, the risk of progression of the systemic arteritis with formation of aneurysms in other arterial districts, such as ITAs [19, 20] , has to be considered too.

Recently published guidelines recommended a tailored approach to individual practice [61, 62] . The standard surgical strategy of myocardial revascularization used in adult patients was not been adequately studied in patients with KD, giving rise to numerous speculations. The use of bilateral thoracic artery was appealing in younger patients, although diabetes, obesity, chronic obstructive disease, and female sex remained adverse factors and should be taken into serious consideration even in adult patients. The radial artery represented a valid alternative to the saphenous vein with encouraging medium to long-term results. The right gastroepiploic and inferior epigastric arteries remain of limited application with less supporting evidence for their usage in the adults. Allografts and artificial grafts are very rarely, if ever, used. The choice of conduit should be addressed for each patient or group of patients and balanced on anatomical criteria, patient background, conduit availability, and surgical expertise [18, 61, 62] .

In the future, we could assist in a rising number of KD cases due to the potential association with pediatric COVID-19 [63] , for which it is even more actual and important to know the better strategy of treatment for coronary complications after KD.

To assess the latter, in this study we compared graft patency of ITA, SV, and other arteries (gastroepiploic artery and radial artery); and patients treated with arterial, venous, and mixed (arterial plus second venous graft) CABG to assess long-term mortality.

Our meta-analysis demonstrated that arterial conduits provided better patency rates at 10 years followup, with ITAs as the first most effective surgical option, when compared to SV. No progression of the systemic arteritis in other arterial districts was detected in the included studies.

Arterial or mixed (arterial plus a second venous graft) CABG, seen as a surrogate for the use of arterial conduits for revascularization, has been shown to be associated with higher patients' survival rates. This result complies with the superiority of the arterial grafts when used for surgical myocardial revascularization for KD patients.

We have identified the following limits. Network metaanalyses for early mortality, need of interventional procedures, and surgical re-interventions were not conducted. Randomized clinical trial evidences for graft patency following CABG after KD were not published. We pooled observational studies results on the topic, including not adjusted comparative studies. This is a potential source of underpowering that increases heterogeneity where there is variability between patency results. Moreover, a low-moderate risk of bias for the included studies should be taken into account in the interpretation of the results. Nevertheless, this systematic review and meta-analysis represents an overview of the surgical myocardial revascularization in KD and may represent a starting point for further studies and refinement of the technique.

Meta-regression has not been applied. It is unlikely that this represents a source of bias since young patients with few comorbidities have been included in this review. Given that, it cannot certainly be excluded since <5% of patients develop obstructive lesions resulting in ischemic coronary disease regardless of the administration of gamma-globulins [8] . Graft patency was compared regardless of the territory of revascularization. "Grey literature" was not investigated. Furthermore, as the included studies were published between 1981 and 2019, improvements in patency outcomes or long-term mortality could be expected to vary over time due to operative and therapeutic improvements.

In conclusion, our results demonstrate that CABG in KD is a safe procedure, with an overall early mortality rate of 0.28% and rates of surgical re-interventions and interventional procedures at follow-up of 3.47% and 3.97%, respectively. The use of arterial conduits was associated with better patency rates and lower mortality at follow-up.

A. S., J. L., A. M.: conceptual design, data collecting, statistical analysis, writing, language editing, revision. M. C., G. M., F. S., A. F. C.: conceptual design, data collecting, writing, revision.

Antonio Salsano declares to be Section Editor in Open Medicine, but this fact hasn't affected the peer-review process. The other coauthors state no conflict of interest.

Data availability statement: All data generated or analysed during this study are included in this published article (and its supplementary information files).

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan

Pathology of the heart in Kawasaki disease

Pathological observations concerning the cardiovascular lesions in Kawasaki disease

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome

Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases

Kawasaki disease. Front Pediatr

Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association

Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation

European consensus-based recommendations for the diagnosis and treatment of Kawasaki diseasethe SHARE initiative. Rheumatol (Oxford)

Left ventricular function in patients with coronary arteritis due to acute febrile mucocutaneous lymph node syndrome or related diseases

Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function

Longterm outcome of coronary artery dilatation in Kawasaki disease

Myocardial perfusion, fibrosis, and contractility in children with Kawasaki disease

Utility of coronary computed tomography angiography in the diagnosis and management of acute-phase adult-onset Kawasaki disease

Difference between persistent aneurysm, regressed aneurysm, and coronary dilation in Kawasaki disease: an optical coherence tomography study

Giant coronary aneurysms, from diagnosis to treatment: a literature review

Review: surgical treatment of giant coronary aneurysms in pediatric patients with Kawasaki disease

Pediatric nonaortic arterial aneurysms

Atypical Kawasaki disease: a patient with coronary, brain, and internal mammary arteritis

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

Methods Work Group Third US preventive services task force. Current methods of the US preventive services task force: a review of the process

Cochrane handbook for systematic reviews of interventions

BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network meta-analyses

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis

Automating network meta-analysis

Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Mak

Meta-analysis with R

Robotic minimally invasive direct coronary artery bypass for Kawasaki disease

Multiple coronary artery bypass grafting for Kawasaki disease-associated coronary artery disease

Coronary artery bypass grafting with arterial grafts in patients with Kawasaki disease affecting the coronary artery: a Korean single-center study

Surgical treatment of coronary artery aneurysms

Coronary revascularization in children at a Mexican cardiac center: thirteen-year outcomes

Coronary artery bypass grafting and percutaneous coronary intervention after Kawasaki disease: the pediatric Canadian series

Nationwide survey of coronary aneurysms with diameter >6 mm in Kawasaki disease in Korea

A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease

Coronary artery bypass grafting for Kawasaki disease

Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease

Midterm outcomes of myocardial revascularization in children

Outcome of coronary artery bypass grafting performed in young children

Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease

Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions

Longterm results of saphenous vein graft for coronary stenosis caused by Kawasaki disease

Two adult cases of coronary artery aneurysms secondary to Kawasaki disease

Competition between native flow and graft flow after coronary artery bypass grafting. Impact on indications for coronary artery bypass grafting for localized stenosis with giant aneurysms due to Kawasaki disease

Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children

Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation

Optimal time of surgical treatment for Kawasaki coronary artery disease

Follow-up study of coronary artery bypass grafting in patients with Kawasaki disease

Twentytwo-year follow-up of saphenous vein grafts in pediatric Kawasaki disease

Result of surgical treatments in patients with coronary-arterial obstructive disease after Kawasaki disease

Pediatric coronary artery bypass for Kawasaki congenital, post arterial switch, and iatrogenic lesions

Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study

Aortocoronary bypass surgery for coronary arterial lesions resulting from Kawasaki disease

Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease)

Cardiac surgery of eight children with Kawasaki disease (mucocutaneous lymph node syndrome)

Long-term results in surgical treatment of children 4 years old or younger with coronary involvement due to Kawasaki disease

Early and mid-term results of right gastroepiploic artery grafting in the children with Kawasaki disease. Nihon Kyobu Geka Gakkai Zasshi

Follow-up study of coronary artery bypass grafting after Kawasaki disease -early and late postoperative evaluation

Comparative studies of various conduits for myocardial revascularization with Kawasaki disease

Society of thoracic surgeons. The society of thoracic surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting

How I choose conduits and configure grafts for my patients-rationales and practices. Ann Cardiothorac Surg

COVID-19 and Kawasaki disease: novel virus and novel case